Canadian Securities ExchangeThe Daily Bell
Magazine

Canadian Securities Exchange Magazine: The Global Issue – Now Live!

December 18, 20252 min read

Welcome to the latest issue of Canadian Securities Exchange Magazine, your source for in-depth stories of entrepreneurs from a wealth of different industries.

The global capital markets map is being redrawn in real time. Economies are facing an inflection point: never before has the world been more interconnected through technology and trade; however, geopolitical tensions and economic uncertainties have created new barriers to interoperability. Many CSE listed companies are showcasing what happens when innovation refuses to concede to complacency, demonstrating that entrepreneurial vision paired with strategic execution can transcend complex geographic constraints. 

In this issue of Canadian Securities Exchange Magazine, discover the stories of nine CSE listed companies taking on global challenges in defence, healthcare, technology, and beyond. Plus, WFE CEO Nandini Sukumar shares how the global network of exchanges enables innovation and sustainability around the world, and we spotlight National Stock Exchange of Australia Managing Director and CEO Max Cunningham.

The CSE listed companies featured in this issue include:

Check out The Global Issue of Canadian Securities Exchange Magazine here:

Keep Reading

Read the blog

Jul 12, 2023Magazine

Canadian Securities Exchange Magazine: The Technology Issue – Now Live!

Welcome to the latest issue of Canadian Securities Exchange Magazine, your source for in-depth stories of entrepreneurs from a wealth of different industries. Just two months after being released publicly in November 2022, OpenAI’s ChatGPT grew to 100 million users. For the more than 800 listings on the CSE, over 100 of which are technology…

(CSE:BHSC) and 5 more

Jan 21, 2026CSE Issuer Stories

Epilepsy Drug in Phase II Trials and Peer Success Combine to Fuel a Standout Year

For three decades, central nervous system (CNS) drug development was a tough space for investors, scarred by failed bets on Alzheimer’s disease, plateauing first-generation antidepressants, and setbacks in safety and efficacy. But advances in receptor-selective chemistry and so-called “biased agonism” – steering toward therapeutic pathways and away from areas that cause side effects – are…

Bright Minds Biosciences Inc. (CSE:DRUG)

Jan 14, 2026CSE Issuer Stories

Recent Earnings Results Validate Cannabis and Alcohol Strategy

North America’s legal cannabis industry is still in the early stages of development, shaped by complex regulation, high taxes, and fierce competition – pressures that only the most capable management teams can navigate. That dynamic is clear when speaking with SNDL (CSE:SNDL) Chief Executive Officer Zachary George, who anticipated how the industry would evolve, the…

SNDL Inc. (CSE:SNDL)